This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Clanotech Ab. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Yihai Cao: Innovator in Medical Therapy
Introduction
Yihai Cao is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of medical therapy, particularly through his innovative work on quinoline compounds. His research focuses on developing treatments for fibrosis and related diseases.
Latest Patents
Yihai Cao holds a patent for quinoline compounds that act as anti-angiogenic integrin alpha5 beta1 inhibitors. This patent is particularly relevant for the treatment of fibrosis or fibrosis-related diseases. The compounds are designed to target various fibrotic conditions affecting organs such as the lung, liver, kidney, skin, and more.
Career Highlights
Throughout his career, Yihai Cao has worked with several companies, including Clanotech AB and Sun. His expertise in medical therapy has positioned him as a valuable contributor to advancements in the treatment of fibrotic diseases.
Collaborations
Yihai Cao has collaborated with notable individuals in his field, including his coworker Sun Baocun. Their joint efforts have furthered research and development in medical therapies.
Conclusion
Yihai Cao's innovative work in developing quinoline compounds showcases his commitment to improving medical treatments for fibrosis-related diseases. His contributions are significant in the ongoing quest for effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile